He Ministry of Health has published this Monday the main agreements established by the Interministerial Commission on Medicine Prices (CIPM) at its ordinary meeting on December 15, the last of 2022. In it, the green light was given to include in the public financing of the National Health System (SNS) seven new drugs, as well as two new indications. In addition, the inclusion of nine new drugs has been rejected.
Informative advance – Medical Writing is expanding this news
Although it may contain statements, data or notes from health institutions or professionals, the information contained in Redacción Médica is edited and prepared by journalists. We recommend to the reader that any health-related questions be consulted with a health professional.